High Dose CBD Capsules

Coming soon:

The only product

available for twice-daily

high-dose protocols

300-600 mg pure CBD per capsule

Enhanced bioavailability

High dose CBD was clinically tested for Schizophrenia, Parkinson's, Autism, Epilepsy, and more.

Schizophrenia

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Published: 20 March 2012

Opiate addiction withdrawal syndrome

Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

Published: 12 October 2015

Epilepsy

Cannabidiol in patients with treatment-resistant epilepsy:

an open-label interventional trial

Published: March 2016

Alzheimer’s Disease

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease

Published: 03 February 2013

Parkinson’s Disease

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial

Published: 18 September 2014